RNK08954-01 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 2mo
ESTIMATED |
READOUT
A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten R
Phase 1/2 · KRAS G12D Mutation |
Ranok Therapeutics (Hangzhou) Co., | RNK08954-01 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|